Unique therapy helps patient beat prostate cancer
Focal therapy, a treatment unique to the region and only offered at UC, helped Richard Weiss, 72, overcome prostate cancer with minimal side effects.
A diagnosis with prostate cancer was something Dick Weiss, 72, was not anticipating in May 2017, after his prostate-specific antigen (PSA) test came back higher than normal. After finding his way to a support group in Blue Ash for men with prostate cancer, he encountered experts from the University of Cincinnati Cancer Institute who were offering unique procedures, not offered elsewhere in the Tristate, to treat this type of cancer.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.